Off-target effects of epidermal growth factor receptor antagonists mediate retinal ganglion cell disinhibited axon growth.
about
PI3K p110γ deletion attenuates murine atherosclerosis by reducing macrophage proliferation but not polarization or apoptosis in lesions.Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injuryCombined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling.Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms.Ocular neuroprotection by siRNA targeting caspase-2Decorin treatment of spinal cord injuryPharmacological inhibition of caspase-2 protects axotomised retinal ganglion cells from apoptosis in adult ratsAMIGO3 is an NgR1/p75 co-receptor signalling axon growth inhibition in the acute phase of adult central nervous system injury.Nanospheres delivering the EGFR TKI AG1478 promote optic nerve regeneration: the role of size for intraocular drug delivery.Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adipose-derived mesenchymal stem cellsTransforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injuryMechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation.Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damageDNA Aptamer Assembly as a Vascular Endothelial Growth Factor Receptor AgonistEye drop delivery of pigment epithelium-derived factor-34 promotes retinal ganglion cell neuroprotection and axon regeneration.RegenBase: a knowledge base of spinal cord injury biology for translational researchPigment epithelium-derived factor is retinal ganglion cell neuroprotective and axogenic after optic nerve crush injury.Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNFNogo-A represses anatomical and synaptic plasticity in the central nervous system.New Insights into the Roles of Nogo-A in CNS Biology and Diseases.In vitro models of axon regeneration.Sphingosine 1-phosphate (S1P) induced interleukin-8 (IL-8) release is mediated by S1P receptor 2 and nuclear factor κB in BEAS-2B cellsHuman Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.Receptor tyrosine kinases: molecular switches regulating CNS axon regeneration.ErbB1 epidermal growth factor receptor is a valid target for reducing the effects of multiple inhibitors of axonal regeneration.ErbB2 blockade with Herceptin (trastuzumab) enhances peripheral nerve regeneration after repair of acute or chronic peripheral nerve injury.Induction of neuronal phenotypes from NG2+ glial progenitors by inhibiting epidermal growth factor receptor in mouse spinal cord injury.
P2860
Q31133175-63329D38-E54C-4915-9B47-4DECC491A63FQ33647461-3723536E-0F89-4172-BD8E-9942E9369270Q33654204-D0177FAA-4AD8-487B-B7B2-BBFA97FA2849Q33722613-CDD4163B-2421-447E-887A-44E62B8546CEQ34192944-0E9AC764-50EB-40BB-9F31-984F66D8EB43Q34412717-45CBE75E-D50D-450A-B736-E949D0CC1FCBQ34535261-0EDDC474-BBEC-4D1E-9870-6390CBD4A5D7Q34685351-8D953434-D811-45BD-B5B6-D69BB8238217Q35105415-0A35F3A7-99C1-47D7-8CE7-81CF472E13D8Q35309383-7532B99B-B62B-479B-BA58-A7C2E0C93221Q35543006-8DD04638-3C34-4E4E-8BF6-297725184FC5Q35911995-3D9DBB4B-3CCA-47AD-B33A-FD9DF3BFE71AQ35924101-6647AAC0-4DFD-4E18-A139-F309D9FC0C8EQ36078454-538A0B04-765E-4BB2-A736-196DB266C63AQ36159673-7AA4C45D-EB44-4D41-B22E-558846BA29D5Q36774566-6CEC6BA0-B1FB-4F29-8DA9-0C31EEC4A843Q36779341-4C1D7EB5-22FF-45AA-ADFB-B64F50F2DFA7Q37481542-197F706C-40D5-440E-802C-E36B6EB5FB2DQ38103436-7BD52BF2-B857-4042-9133-F079ADE661C4Q38565299-AB141261-D1BC-4836-89FF-01C68660C0B4Q38716618-52EBFAF4-132D-4E73-BC9C-A0E02208A930Q38813531-0C3A2017-5406-46EC-BD6D-A521105B35A8Q39100413-69DEC4FA-2CC2-4DCD-9C9A-28BC645FA929Q41819306-64954606-3593-4809-B4F1-BA822D88222EQ43031168-7E3A61FE-3B6F-4632-8DDD-A366449D56BAQ51339711-38443242-7228-4C14-9F0A-37E72A090E3FQ53153031-91ED6710-B420-4FBF-9E5E-C850B64E26C3
P2860
Off-target effects of epidermal growth factor receptor antagonists mediate retinal ganglion cell disinhibited axon growth.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Off-target effects of epiderma ...... cell disinhibited axon growth.
@en
Off-target effects of epiderma ...... cell disinhibited axon growth.
@nl
type
label
Off-target effects of epiderma ...... cell disinhibited axon growth.
@en
Off-target effects of epiderma ...... cell disinhibited axon growth.
@nl
prefLabel
Off-target effects of epiderma ...... cell disinhibited axon growth.
@en
Off-target effects of epiderma ...... cell disinhibited axon growth.
@nl
P2093
P2860
P356
P1433
P1476
Off-target effects of epiderma ...... cell disinhibited axon growth.
@en
P2093
Ana Maria Gonzalez
Kevin C Morrison
Martin Berry
Michael R Douglas
Steven J Jacques
Wendy E Leadbeater
Zubair Ahmed
P2860
P304
P356
10.1093/BRAIN/AWP240
P407
P50
P577
2009-09-25T00:00:00Z